Literature DB >> 8875201

Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer.

H Bonkhoff1.   

Abstract

OBJECTIVES: Prostatic intraepithelial neoplasias (PIN) result from abnormal differentiation and proliferation processes within the prostatic epithelial cell system. Recent data indicate that basal cells are essentially involved in normal and abnormal growth patterns of the human prostate.
RESULTS: The basal cell layer represents the proliferative compartment and most probably houses the prostatic stem cell population. Basal cells are targets of several regulatory factors including estrogens, androgens, epidermal growth factor and other nonsteroidal growth factors. During the malignant transformation of the prostatic epithelium (PIN), the basal cell layer loses its proliferative function which is transferred to secretory luminal cell types. These proliferative abnormalities are attended by severe regulatory disorders of the programmed cell death within the prostatic epithelial cell system. The Bcl-2 oncoprotein which blocks the programmed cell death in the proliferative compartment (basal cell layer) in normal conditions, extends to the secretory luminal cell types in high-grade PIN lesions. This, in turn, may increase the genetic instability of the dysplastic epithelium. During the process of tumor invasion, the transformed cells lose their basal cell-specific phenotype and acquire features of exocrine cell types which represent the major phenotype in common prostate cancer. At the point of stromal invasion, the transformed cells produce neoplastic basement membrane material which allows them to penetrate the extracellular matrix.
CONCLUSION: These data provide theoretical bases for a stem cell concept in the development of prostate cancer and highlights the importance of basal cells in this multifactorial process.

Entities:  

Mesh:

Year:  1996        PMID: 8875201     DOI: 10.1159/000474170

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  29 in total

1.  The complexities of identifying a cell of origin for human prostate cancer.

Authors:  Gail P Risbridger; Renea A Taylor
Journal:  Asian J Androl       Date:  2010-10-18       Impact factor: 3.285

2.  Integrin-dependent amplification of the G2 arrest induced by ionizing radiation.

Authors:  Celeste L Kremer; Monika Schmelz; Anne E Cress
Journal:  Prostate       Date:  2006-01-01       Impact factor: 4.104

3.  Prostate epithelial stem cell culture.

Authors:  David L Hudson
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

4.  A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.

Authors:  E M Garabedian; P A Humphrey; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

5.  Multi-Drug Resistance ABC Transporter Inhibition Enhances Murine Ventral Prostate Stem/Progenitor Cell Differentiation.

Authors:  Mugdha D Samant; Courtney M Jackson; Carina L Felix; Anthony J Jones; David W Goodrich; Barbara A Foster; Wendy J Huss
Journal:  Stem Cells Dev       Date:  2015-02-25       Impact factor: 3.272

6.  Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.

Authors:  R E Reiter; Z Gu; T Watabe; G Thomas; K Szigeti; E Davis; M Wahl; S Nisitani; J Yamashiro; M M Le Beau; M Loda; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

7.  Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma.

Authors:  Simion Chiosea; Elena Jelezcova; Uma Chandran; Marie Acquafondata; Teresa McHale; Robert W Sobol; Rajiv Dhir
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

8.  Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.

Authors:  S M Goodyear; M D Amatangelo; M E Stearns
Journal:  Prostate       Date:  2009-05-15       Impact factor: 4.104

Review 9.  [New insights into the role of estogens and their receptors in prostate cancer].

Authors:  H Bonkhoff; H Motherby; T Fixemer
Journal:  Urologe A       Date:  2003-12       Impact factor: 0.639

10.  Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling.

Authors:  Pilar Sanchez; Ana Maria Hernández; Barbara Stecca; Andrea J Kahler; Amy M DeGueme; Andrea Barrett; Mercedes Beyna; Milton W Datta; Sumana Datta; Ariel Ruiz i Altaba
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.